GlobeNewswire by notified

Roche Annual General Meeting 2022

Share
  • All proposals of the Board of Directors approved
  • Christoph Franz as Chairman of the Roche Board of Directors and all other Board members standing for re-election approved;
    Jemilah Mahmood elected as a new member of the Board of Directors
  • 35th Consecutive dividend increase to CHF 9.30 per share

Basel, 15 March 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its shareholders approved all proposals of the Board of Directors at its ordinary Annual General Meeting (AGM). Owing to the ongoing high infection rates, the AGM was held with only representatives of Roche Holding Ltd and those persons required by the Articles of Incorporation in attendance and with no shareholders physically present. The AGM was broadcast live on the Internet. Roche shareholders were able to exercise their rights via written or electronically submitted instructions to the independent proxy, Testaris AG. The independent proxy represented 77.25% of the total of 106,691,000 shares. The Management Report, the Financial Statements and the Consolidated Financial Statements for 2021 were approved.

Christoph Franz was confirmed as Chairman of the Board of Directors with 98.91% of the votes. He addressed shareholders in a speech published online today:

"In 2021, in which we celebrated our 125th anniversary, we have once again been able to develop and manufacture innovative diagnostics and therapies against serious illnesses and, in particular, against COVID-19, and make them accessible to the world. Despite the ongoing coronavirus pandemic, 2021 was a good year for Roche. This enables us to raise the dividend for the 35th consecutive time to 9.30 Swiss francs per share. We are proud of the contributions that our Diagnostics and Pharmaceuticals Divisions have made to combating the pandemic. At the same time, we have been able to make great progress in our product pipeline across several areas, including oncology, vision loss and neurological diseases."

Shareholders endorsed the total amount of bonuses paid to the Corporate Executive Committee for 2021 with 98.53% of the votes, as well as the total amount of bonuses paid to the Chairman of the Board of Directors for 2021, which was approved by 98.54% of the votes. Furthermore, shareholders authorised the ratification of the Board of Directors’ actions.

Shareholders approved the proposed appropriation of available earnings with 99.93% of the votes. They also approved an increase in the dividend for the past financial year from 9.10 to 9.30 Swiss francs (gross) per share and non-voting equity security. This is the 35th consecutive dividend increase.

In addition to Dr Christoph Franz, all other Board members who stood for re-election were confirmed for a term of one year:

●        André Hoffmann
●        Julie Brown
●        Dr Jörg Duschmalé
●        Dr Patrick Frost
●        Anita Hauser
●        Professor Dr Richard P. Lifton
●        Bernard Poussot
●        Dr Severin Schwan
●        Dr Claudia Süssmuth Dyckerhoff

Professor Dr Jemilah Mahmood was elected as a new member of the Board of Directors for a term of one year.

The following Board members were re-elected to the Remuneration Committee for a term of one year:

●        Dr Christoph Franz
●        André Hoffmann
●        Professor Dr Richard P. Lifton
●        Bernard Poussot

Dr Patrick Frost was elected as a new member of the Remuneration Committee for a term of one year.

Shareholders also approved the maximum total amount of future remuneration of the Board of Directors, which was confirmed by 98.59% of the votes, and the maximum total amount of future remuneration for the Corporate Executive Committee until the 2023 ordinary Annual General Meeting by 98.50% of the votes.

The Meeting elected Testaris AG as independent proxy for the 2022 financial year until the conclusion of the 2023 ordinary Annual General Meeting and KPMG AG as external auditor for the financial year 2022.

To create the greatest possible transparency, this year's AGM was broadcast live on the Internet. The speech by Chairman of the Board Christoph Franz to shareholders can be found at https://www.roche.com/de/about/governance/annual_general_meetings.htm.


About Roche

Founded in1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.

In recognising our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work.

Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

For more information, please visit www.roche.com.

Roche Group Media Relations
Phone: +41 61 688 8888 / e-mail: media.relations@roche.com

Dr. Nicolas Dunant
Phone: +41 61 687 05 17
SileiaUrech
Phone: +41 79 935 81 48

Dr. Barbara von Schnurbein
Phone: +41 61 687 89 67
KarstenKleine
Phone: +41 61 682 28 31

Nina Mählitz
Phone: +41 79 327 54 74
Nathalie Meetz
Phone: +41 61 687 43 05

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

US Foods Partners With Vertical Farming Innovator Kalera® to Expand Its Local and Sustainable Fresh Produce Portfolio18.5.2022 09:00:00 CEST | Press release

National Vertical Farming Partnership for US Foods Brings Consistent Year-Round Availability of High-Quality Leafy Greens to Customers ROSEMONT, Ill., May 18, 2022 (GLOBE NEWSWIRE) -- US Foods Holding Corp. (NYSE: USFD) today announced a strategic agreement with Kalera®, one of the world’s leading hydroponic indoor vertical farming companies. This is US Foods’ largest vertical farming relationship to date. The agreement underscores US Foods’ commitment to bringing foodservice operators a broad assortment of high-quality produce, year-round. It will also expand the portfolio of local farms that US Foods is sourcing from in various markets in support of its growing Serve Local program. As part of the agreement, Kalera and its wholly owned seed technology business Vindara, will work closely with US Foods to develop and launch new products to US Foods customers in markets across the country. Kalera will bring consistently fresh, sustainable produce year-round to US Foods through its networ

Eolus Vind AB Interim Report 1 January–31 March 202218.5.2022 08:30:00 CEST | Press release

1 January–31 March 2022 Net sales amounted to 432 (242) MSEK.EBIT amounted to -158 (-29) MSEK. Profit before tax amounted to -159 (-21) MSEK.Net profit amounted to -138 (-17) MSEK.Earnings per share, before and after dilution equaled -5.55 (-0.67) SEK.During the period, energy facilities with a total installed capacity of 0 (0) MW were taken into operations and handed over to customer.At the end of the period Eolus had 914 (874) MW under asset management. Significant events during the period Previously communicated delays for Öyfjellet have continued to affect the project and impaired the profitability forecast.Financial goals were communicated based on the business plan for 2022–2024.Eolus placed order for 16 wind turbines with Siemens Gamesa for the projects Skallberget/Utterberget and Tjärnäs in Sweden.Magnus Axelsson was recruited as new Chief Operating Officer.Karin Wittsell Heydl was recruited as Head of Communications, Sustainability and IT. Significant events after the balance

Eolus Vind AB delårsrapport 1 januari–31 mars 202218.5.2022 08:30:00 CEST | Pressemelding

Hässleholm den 18 maj 2022 1 januari–31 mars 2022 Nettoomsättningen uppgick till 432 (242) MSEK.Rörelseresultatet uppgick till -158 (-29) MSEK. Resultat före skatt uppgick till -159 (-21) MSEK.Periodens resultat efter skatt uppgick till -138 (-17) MSEK.Resultat per aktie före och efter utspädning uppgick till -5,55 (-0,67) SEK.Under perioden togs energianläggningar med en total effekt om 0 (0) MW i drift och överlämnades till kunder.Vid periodens utgång omfattade koncernens förvaltningsverksamhet 914 (874) MW. Väsentliga händelser under perioden Tidigare kommunicerade förseningar för Öyfjellet har fortsatt påverka projektet och försämrat lönsamhetsprognosen.Finansiella målsättningar kommunicerades baserade på affärsplan 2022–2024.Eolus lade en order på 16 vindkraftverk hos Siemens Gamesa till projekten Skallberget/Utterberget och Tjärnäs.Magnus Axelsson anställdes som operativ chef och vice VD i moderbolaget.Karin Wittsell Heydl anställdes som chef för kommunikation, hållbarhet och IT.

Snam and Golar LNG sign agreement for an FSRU to supply Sardinia with energy18.5.2022 08:15:00 CEST | Press release

San Donato Milanese (Milan), Bermuda – May, 18, 2022 – Snam and Golar LNG Limited (“Golar”) signed a contract through which Golar will deliver the existing LNG Carrier “Golar Arctic” as a floating storage and regasification unit (FSRU) that Snam will install in the port area of Portovesme, in Sardinia, as part of a project to supply the island with energy. The contract, for a total consideration of 269 million euros, includes the vessel and the capex for Golar to convert the Golar Arctic into an FSRU with storage capacity for up to 140,000 cubic meters. Further to the full conversion of the vessel, the FSRU will be sold to the Snam Group. Start of activities for the conversion of the ship into an FSRU and related fulfillments are subject to Snam’s issuance of a Notice-to-Proceed (NTP) and further to that the conversion is expected to take about two years for the Golar Arctic to be delivered. Forward-Looking Statements This press release contains forward-looking statements (as defined i

Sampo completes its share buyback programme18.5.2022 08:15:00 CEST | Press release

SAMPO PLC STOCK EXCHANGE RELEASE 18 May 2022 at 9:15 am Sampo completes its share buyback programme Sampo plc has now completed its share buyback programme. The repurchases of shares began on 31 March 2022 and ended on 17 May 2022. During that period, Sampo repurchased 4,961,994 of its own shares at an average price per share of EUR 45.85. The amount corresponds to 0.9 per cent of all Sampo plc’s shares. The repurchase of own shares has reduced the company's unrestricted equity by approximately EUR 228 million. The purpose of the buyback programme was to return excess capital to shareholders by reducing Sampo plc’s capital, as the repurchased shares will be cancelled. Management intends to propose to the Board that a new share buyback programme is launched after the Annual General Meeting on 18 May 2022, subject to the AGM renewing the Board authorisation on share repurchases. The Board will make a decision on the proposal at the next regular meeting, which takes place on 9 June 2022.